These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
154 related articles for article (PubMed ID: 37981707)
1. One-step preparation of a self-assembled bioconjugate nanovaccine against Huang J; Guo Y; Yu S; Wang D; Li S; Wu J; Sun P; Zhu L; Wang H; Pan C Virulence; 2023 Dec; 14(1):2280377. PubMed ID: 37981707 [TBL] [Abstract][Full Text] [Related]
2. Application of an Huang J; Pan C; Sun P; Feng E; Wu J; Zhu L; Wang H Microorganisms; 2020 Mar; 8(3):. PubMed ID: 32244903 [TBL] [Abstract][Full Text] [Related]
3. Brucella suis strain 2 vaccine is safe and protective against heterologous Brucella spp. infections. Zhu L; Feng Y; Zhang G; Jiang H; Zhang Z; Wang N; Ding J; Suo X Vaccine; 2016 Jan; 34(3):395-400. PubMed ID: 26626213 [TBL] [Abstract][Full Text] [Related]
4. Overexpression of wbkF gene in Brucella abortus RB51WboA leads to increased O-polysaccharide expression and enhanced vaccine efficacy against B. abortus 2308, B. melitensis 16M, and B. suis 1330 in a murine brucellosis model. Dabral N; Burcham GN; Jain-Gupta N; Sriranganathan N; Vemulapalli R PLoS One; 2019; 14(3):e0213587. PubMed ID: 30856219 [TBL] [Abstract][Full Text] [Related]
5. Improved influenza viral vector based Brucella abortus vaccine induces robust B and T-cell responses and protection against Brucella melitensis infection in pregnant sheep and goats. Mailybayeva A; Yespembetov B; Ryskeldinova S; Zinina N; Sansyzbay A; Renukaradhya GJ; Petrovsky N; Tabynov K PLoS One; 2017; 12(10):e0186484. PubMed ID: 29023541 [TBL] [Abstract][Full Text] [Related]
6. Bm Delta-pgm, a vaccine for the control of Brucella melitensis with cross-species protective properties. Czibener C; Rey Serantes DA; Romani AM; Bruno L; Pasquevich KA; Cassataro J; Comerci DJ; Ugalde JE Vaccine; 2023 May; 41(23):3534-3543. PubMed ID: 37149444 [TBL] [Abstract][Full Text] [Related]
7. Mannosylated chitosan nanoparticles loaded with FliC antigen as a novel vaccine candidate against Brucella melitensis and Brucella abortus infection. Sadeghi Z; Fasihi-Ramandi M; Azizi M; Bouzari S J Biotechnol; 2020 Feb; 310():89-96. PubMed ID: 32017955 [TBL] [Abstract][Full Text] [Related]
8. Yersinia enterocolitica as a vehicle for a naked DNA vaccine encoding Brucella abortus bacterioferritin or P39 antigen. Al-Mariri A; Tibor A; Lestrate P; Mertens P; De Bolle X; Letesson JJ Infect Immun; 2002 Apr; 70(4):1915-23. PubMed ID: 11895955 [TBL] [Abstract][Full Text] [Related]
9. Improved immunogenicity and protective efficacy of a divalent DNA vaccine encoding Brucella L7/L12-truncated Omp31 fusion protein by a DNA priming and protein boosting regimen. Golshani M; Rafati S; Siadat SD; Nejati-Moheimani M; Shahcheraghi F; Arsang A; Bouzari S Mol Immunol; 2015 Aug; 66(2):384-91. PubMed ID: 25968974 [TBL] [Abstract][Full Text] [Related]
10. Studies on recombinant glucokinase (r-glk) protein of Brucella abortus as a candidate vaccine molecule for brucellosis. Vrushabhendrappa ; Singh AK; Balakrishna K; Sripathy MH; Batra HV Vaccine; 2014 Sep; 32(43):5600-6. PubMed ID: 25131740 [TBL] [Abstract][Full Text] [Related]
11. Contrasting roles for IgM and B-cell MHCII expression in Abushahba MFN; Dadelahi AS; Ponzilacqua-Silva B; Moley CR; Skyberg JA mSphere; 2024 Mar; 9(3):e0075023. PubMed ID: 38349167 [TBL] [Abstract][Full Text] [Related]
12. Nanoparticle-Based Vaccines for Brucellosis: Calcium Phosphate Nanoparticles-Adsorbed Antigens Induce Cross Protective Response in Mice. Sadeghi Z; Fasihi-Ramandi M; Bouzari S Int J Nanomedicine; 2020; 15():3877-3886. PubMed ID: 32581535 [TBL] [Abstract][Full Text] [Related]
14. Non-infectious outer membrane vesicles derived from Brucella abortus S19Δper as an alternative acellular vaccine protects mice against virulent challenge. Solanki KS; Varshney R; Qureshi S; Thomas P; Singh R; Agrawal A; Chaudhuri P Int Immunopharmacol; 2021 Jan; 90():107148. PubMed ID: 33189614 [TBL] [Abstract][Full Text] [Related]
15. Immunization of mice with gamma-irradiated Brucella neotomae and its recombinant strains induces protection against virulent B. abortus, B. melitensis, and B. suis challenge. Moustafa D; Garg VK; Jain N; Sriranganathan N; Vemulapalli R Vaccine; 2011 Jan; 29(4):784-94. PubMed ID: 21109033 [TBL] [Abstract][Full Text] [Related]
16. A bioconjugate vaccine against Li S; Huang J; Wang K; Liu Y; Guo Y; Li X; Wu J; Sun P; Wang Y; Zhu L; Wang H Front Bioeng Biotechnol; 2023; 11():1121074. PubMed ID: 36911199 [TBL] [Abstract][Full Text] [Related]
17. Delta-pgm, a new live-attenuated vaccine against Brucella suis. Czibener C; Del Giudice MG; Spera JM; Fulgenzi FR; Ugalde JE Vaccine; 2016 Mar; 34(13):1524-1530. PubMed ID: 26899373 [TBL] [Abstract][Full Text] [Related]
18. Protection of BALB/c mice against homologous and heterologous species of Brucella by rough strain vaccines derived from Brucella melitensis and Brucella suis biovar 4. Winter AJ; Schurig GG; Boyle SM; Sriranganathan N; Bevins JS; Enright FM; Elzer PH; Kopec JD Am J Vet Res; 1996 May; 57(5):677-83. PubMed ID: 8723881 [TBL] [Abstract][Full Text] [Related]
19. Brucella antigens (BhuA, 7α-HSDH, FliC) in poly I:C adjuvant as potential vaccine candidates against brucellosis. Sadeghi Z; Fasihi-Ramandi M; Bouzari S J Immunol Methods; 2022 Jan; 500():113172. PubMed ID: 34673003 [TBL] [Abstract][Full Text] [Related]
20. The candidate vaccine strain Brucella ovis ∆abcBA is protective against Brucella melitensis infection in mice. Costa LF; Cabello AL; Batista DFA; Chaki SP; de Figueiredo P; da Paixão TA; Rice-Ficht AC; Ficht TA; Santos RL Microbiol Immunol; 2020 Nov; 64(11):730-736. PubMed ID: 32965738 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]